Smith & Nephew

+$0.58 (+1.73%) As of 3:15 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew PLC engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management.

CEO

Roland D. Diggelmann

Employees

17,914

Headquarters

Watford, Herefordshire

Founded

1937

SNN Key Statistics

Market cap

Price-Earnings ratio

26.66

Dividend yield

2.19

Average volume

710.28K

High today

$33.91

Low today

$33.77

Open price

$33.77

Volume

378.84K

52 Week high

$46.10

52 Week low

$32.03

SNN News

Simply Wall StDec 3

Are Investors Undervaluing Smith & Nephew plc By 30%?

Does the December share price for Smith & Nephew plc ( ) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the c

Analyst ratings

Buy

61.5%

Hold

23.1%

Sell

15.4%

SNN Earnings

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Feb 22, Pre-Market

Why Robinhood?

Smith & Nephew PLC engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. View more

Are Investors Undervaluing Smith & Nephew plc By 30%?

62%

Smith & Nephew PLC engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management.